Oruka therapeutics to be added to the nasdaq biotechnology index (nbi)

Menlo park, calif., dec. 18, 2024 (globe newswire) -- oruka therapeutics, inc. (“oruka”) (nasdaq: orka), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced that it is expected to be added to the nasdaq biotechnology index (nasdaq: nbi) (the “nbi”). oruka's addition will become effective prior to market open on monday, december 23rd, 2024.
NDAQ Ratings Summary
NDAQ Quant Ranking